Cite
FGF1ΔHBS delays the progression of diabetic nephropathy in late-stage type 2 diabetes mouse model by alleviating renal inflammation, fibrosis, and apoptosis
MLA
Qian Lin, et al. “FGF1ΔHBS Delays the Progression of Diabetic Nephropathy in Late-Stage Type 2 Diabetes Mouse Model by Alleviating Renal Inflammation, Fibrosis, and Apoptosis.” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1868, Aug. 2022, p. 166414. EBSCOhost, https://doi.org/10.1016/j.bbadis.2022.166414.
APA
Qian Lin, Oscar Chen, John P. Wise, HongXue Shi, Kupper A. Wintergerst, Lu Cai, & Yi Tan. (2022). FGF1ΔHBS delays the progression of diabetic nephropathy in late-stage type 2 diabetes mouse model by alleviating renal inflammation, fibrosis, and apoptosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1868, 166414. https://doi.org/10.1016/j.bbadis.2022.166414
Chicago
Qian Lin, Oscar Chen, John P. Wise, HongXue Shi, Kupper A. Wintergerst, Lu Cai, and Yi Tan. 2022. “FGF1ΔHBS Delays the Progression of Diabetic Nephropathy in Late-Stage Type 2 Diabetes Mouse Model by Alleviating Renal Inflammation, Fibrosis, and Apoptosis.” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1868 (August): 166414. doi:10.1016/j.bbadis.2022.166414.